UPCOMING EVENT
AASLD 2024
The 75th Liver Meeting®
San Diego, CA | Nov. 15-19
Join HistoIndex at AASLD 2024
HistoIndex is excited to return to The Liver Meeting, organized by the American Association for the Study of Liver Diseases (AASLD) (https://www.aasld.org/the-liver-meeting), in San Diego, California. This integral industry event explores the latest advancements in liver pathology, with a significant focus on MASH clinical trials.
We will be showcasing our AI-powered Digital Pathology Platform at the San Diego Convention Center. Drop by our Booth 1225 at Exhibit Hall BC to discover cutting-edge solutions in digital pathology.
Breakfast Reception
15 November 2024, Friday | 7AM-8:30AM PST
Don’t miss our exclusive breakfast meeting on November 15th, 2024, from 7 – 8:30AM PST. While the specific topic and speakers are being finalized, anticipate engaging discussions that shape the future of pathology. We look forward to unveiling detailed updates soon.
Get the latest updates about our events
Posters
Assessment of resmetiron-mediated reductions of steatosis and concomitant ballooning utilizing quantitative SHG imaging
Dean Tai, Rebecca Taub, Yayun Ren, Elaine Chng, and Stephen A. Harrison
Differential anti-fibrotic effects of semaglutide and lanifranor demonstrated by AI DP in the biopsy-confirmed GAN BIO-MASH mouse model with advanced fibrosis and HCC
Xiao Teng, Desiree Abdurrachim, Ashmita Saigal, Qiang Yang, Gideon Ho, Malte Hasle Nielsen, Susanne E. Pors, Chih-Liang Chin, Saswata Talukdar, Asad Abu Bakar Ali, and Michael Feigh
Impact of sampling size on variability of fibrosis assessment in liver biopsies using SHG TPE and AI analysis based fibrosis staging
Kutbuddin Akbary, Elaine Chng, Yayun Ren, Dean Tai, Jonathan A. Fallowfield, Timothy J. Kendall, Nikolai V. Naoumov, David E. Kleiner, and Arun J. Sanyal
NITs as continuous measure of hepatic fibrosis in NAFLD
En Ying Tan, Xian Xuan Eunice Tan, Daniel Q Huang, Jonathan Lee, Margaret Li Peng Teng, Nur Halisah Jumat, Dean Tai, Elaine Chng, Yong Young Dan, and Mark Dhinesh Muthiah
Reducing screen failure rates for NASH clinical trials using ballooning and fibrosis assessment with SHG TPE microscopy and AI analysis – results from the TANDEM trial
Naim Alkhouri, Kutbuddin Akbary, Ya-Yun Ren, Dean Tai, Dominique Brees, and Jossy Kochuparampil
Spatial distribution of collagen in MASLD affects levels of N terminal pro-peptide of type III collagen (PRO-C3)
Jörn M. Schattenberg, Maurice Michel, Christian Labenz, Morten A Karsdal, Diana J Leeming, Peder Frederiksen, Elaine Chng, Yayun Ren, Dean Tai, and Beate K. Straub
The concomitant zonal quantification of qSteatosis and qFibrosis using HI AI DP improved detection of liver injury regression post-bariatric surgery
Vlad Ratziu, Raluca Pais, Judith Aron-Wisnewsky, Frédéric Charlotte, Dean Tai, Elaine Chng, Desiree Abdurrachim, Chih-Liang Chin, Saswata Talukdar, and Asad Abu Bakar Ali
Use of multi-parametric measures to differentiate and better assess fibrosis patterns between baselie and EOT patients in NASH clinical trials – Results from the FALCON-1 and 2 clinical trials
Kutbuddin Akbary, Dean Tai, Yayun Ren, Anne Minnich, and Edgar D. Charles
Validation of the HI AI DP platform as an aiding tool to increase pathologist concordance on fibrosis staging in NASH
Desiree Abdurrachim, Serene Lek, Yongqi Zhou, Chun Kit Wong, Charlene Ong, Ashmita Saigal, Radha Krishnan, Geoffrey Walford, Elaine Chng, Dean Tai, Gideon Ho, Annaswamy Raji, Thomas Forest, Richard Baumgartner, Saswata Talukdar, Chih-Liang Chin, Samuel S Engel, Asad Abu Bakar Ali, David E Kleiner, and Arun J Sanyal